Education, Science, Technology, Innovation and Life
Open Access
Sign In

Exploration on the mechanism of quercetin in treating breast duct dilation based on network pharmacology

Download as PDF

DOI: 10.23977/medsc.2023.040613 | Downloads: 4 | Views: 288

Author(s)

Na Zhang 1, Zhi Li 2, Zhongren Gai 1, Kenian Pan 1, Xinyi Yang 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Xi'an Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, 710021, China

Corresponding Author

Zhi Li

ABSTRACT

Dilation of mammary duct is a chronic nonbacterial inflammation of the breast based on breast duct obstruction, secondary breast duct dilation, periductal inflammation, and plasma cell infiltration.Dilation of mammary duct is a chronic nonbacterial inflammation of the breast based on breast duct obstruction, secondary breast duct dilation, periductal inflammation, and plasma cell infiltration. To analyze the mechanism of quercetin in the treatment of Dilation of mammary duct based on network pharmacology and further explore the modern pharmacological action of quercetin, The related targets of "quercetin" were screened from the TCMSP database; Relevant targets of " Dilation of mammary duct were screened from Genecards database. After the common protein target information of the two was obtained through venny, the protein interaction network was constructed using Cytoscape software, and the hub gene was screened. Use David platform to conduct GO, KEGG and other enrichment analysis on the same targe. Conclusion: There are138 nodes and 2608 edges in the PPI network. These targets mainly include AKT1, IL-6, TP53, TNF, VEGFA, CASP3, IL1B, EGFR, JUN, etc. The results of GO enrichment analysis showed that quercetin is involved in 666 biological processes, 98 cellular composition, and 128 molecular functions. It mainly plays a role in AGE-RAGE signaling pathway in diabetic complications, Pathways in cancer, Lipid and atherosclerosis, and other pathways, Conclusion: Quercetin exerts anti-inflammatory effects in Dilation of mammary duct through multiple pathways and multiple targets, which is a new option for the treatment of Dilation of mammary duct. 

KEYWORDS

Dilation of mammary duct; quercetin; Network Pharmacology; mechanism of action

CITE THIS PAPER

Na Zhang, Zhi Li, Zhongren Gai, Kenian Pan, Xinyi Yang, Exploration on the mechanism of quercetin in treating breast duct dilation based on network pharmacology. MEDS Clinical Medicine (2023) Vol. 4: 83-90. DOI: http://dx.doi.org/10.23977/medsc.2023.040613.

REFERENCES

[1] Zhang JD, Xu JZ, Zhang J, et al. Chinese herbal compound combined with western medicine therapy in the treatment of plasma cell mastitis: a protocol for systematic review and metaanalysis[J]. Medicine (Baltimore), 2020, 99(44): e22858. 
[2] Cromar CD. Plasma-cell mastitis[J]. Br Med J, 1958, 1(5065): 279-280. 
[3] Boffi L, Massimo C. Plasma cell mastitis considered not as a pathological entity itself but as a developmental variety of secretory disease of the breast[J]. Arch De Vecchi Anat Patol, 1958, 28(1): 343-355. 
[4] Yeh ED, Jacene HA, Bellon JR, et al. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach[J]. Radiographics, 2013, 33(7): 2003-2017. 
[5] Hu J, Huang XL. Combining ultrasonography and mammography to improve diagnostic accuracy of plasma cell mastitis [J]. J Xray Sci Technol, 2020, 28(3): 555-561. 
[6] Shi Fengyu, Li Yaqiong, Sun Hao, Wu Jian'an, Wang Lingcheng. Clinical features and risk factors of plasma cell mastitis [J]. China Medical Engineering, 2023, 31(4):41-46.
[7] Han Jiyu. Exploring the clinical characteristics and treatment methods of plasma cell mastitis[J].World Latest Medicine Information, 2018, 18(95):80.
[8] Xu Nana, He Kewen, Liu Zhaoyun, et al. Research progress of mammary ductal ectasia[J]. Progress in Modern General Surgery in China, 2017, 20(01):30-34. 
[9] Wang Pin, Yu Zhigang, Wu Jian, et al. Treatment of mammary ductal ectasia[J]. Chinese Journal of Basic and Clinical Surgery, 2013, 20(12):1428-1431. 
[10] Ru Jinlong, Li Peng, Wang Jinan, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines [J]. Journal of Cheminformatics, 2014, 6:13.  
[11] Liu Z, Guo F, Wang Y, et al. BATMAN⁃TCM: A bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine [J]. Scientific Reports, 2016, 6: 21146.  
[12] Zhao Yanmei, Zhang Jiankang, Cai Zhaobin, et al. Clinical research progress of AKT inhibitors[J]. Modern Chinese Journal of Applied Pharmacy, 2017, 34(4):625-630. 
[13] Han Changchang, Wan Fusheng. Research Progress on AP-1 [J]. Chinese Journal of Cell Biology, 2017, 39(10): 1357-1362. 
[14] Uciechowski P, Dempke WCM. Interleukin-6: A Masterplayer in the Cytokine Network [J]. Oncology. 2020; 98(3): 131-137.  
[15] Omran M, Fouda M, Abdelwahab O A, et al. P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study[J]. European Journal of Gastroenterology & Hepatology, 2020. 
[16] Zusso M, Lunardi V, Franceschini D, et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway[J]. Journal of Neuroinflammation, 2019, 16(1):148. 
[17] Ding Bo, Lin Chengheng, Liu Qian. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro[J]. Journal of Neuroinflammation, 2020, 17(1):302. 
[18] Zhang Cun, Tong Tong, Miao Dechao, Wang Linfeng. Vitamin D inhibits TNF-α induced apoptosis of human nucleus pulposus cells through regulation of NF-kB signaling pathway[J]. Journal of Orthopaedic Surgery and Research, 2021, 16(1):411. 
[19] Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation[J]. Nat Rev Drug Discov, 2012, 11(10): 763-76.

Downloads: 4579
Visits: 198565

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.